AT & S Austria Technologie & Systemtechnik AG
VSE:ATS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AT & S Austria Technologie & Systemtechnik AG
VSE:ATS
|
AT |
|
Trevi Therapeutics Inc
NASDAQ:TRVI
|
US |
|
P
|
Perenti Ltd
XMUN:FWG
|
AU |
|
N
|
Nucor Corp
BMV:NUE
|
US |
|
I
|
IMCD NV
SWB:INX
|
NL |
|
St Joe Co
NYSE:JOE
|
US |
|
Dentsu Group Inc
F:DEN
|
JP |
|
DiaSorin SpA
MIL:DIA
|
IT |
|
C
|
Cameco Corp
SWB:CJ6
|
CA |
|
C
|
Charles River Laboratories International Inc
XMUN:RV6
|
US |
|
Societe Generale SA
PAR:GLE
|
FR |
|
A
|
Avvaa World Health Care Products Inc
OTC:AVVH
|
CA |
|
A
|
Antofagasta PLC
DUS:FG1
|
UK |
|
B
|
Briacell Therapeutics Corp
TSX:BCT
|
CA |
|
N
|
National Grid PLC
XMUN:NNGF
|
UK |
|
Maxvalu Tokai Co Ltd
TSE:8198
|
JP |
|
P
|
Perenti Global Ltd
OTC:AUSDF
|
AU |
DCF Value
The DCF Value for AT & S Austria Technologie & Systemtechnik AG (ATS) under the Base Case is hidden EUR. Compared with the current market price of 202 EUR, the stock appears hidden .